Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aiju Biotechnology (Shandong) is a private Chinese biotechnology company founded in 2022 and based in Binzhou, Shandong. Publicly available registry information indicates the company is focused on biologically derived agricultural and industrial products rather than human therapeutics, with activities including biopesticide R&D, bio-organic fertilizers, biomaterials, feed additives, and related production and sales. The company appears to be active and operating, with import-export activity reported by trade databases. Based on available evidence, it does not appear to be a life science, biopharma, or healthcare company in the sense of developing human drugs, diagnostics, or medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIJU.